Immunotherapy for Earlier Stages of Melanoma
The FDA approved an immune checkpoint inhibitor for patients with stage IIB or IIC melanoma following surgical removal of...
Progress Against Cancer
The FDA approved an immune checkpoint inhibitor for patients with stage IIB or IIC melanoma following surgical removal of...
The FDA approved a monoclonal antibody combined with chemotherapy TO TREAT certain childhood blood cancers that express the protein...
The U.S. FDA approved a new combination of existing drugs to treat certain patients with multiple myeloma The U.S....
A new drug approved by the U.S. FDA may help surgeons find cancer more easily and reduce the likelihood...
The U.S. FDA approved the first treatment for malignant perivascular epithelioid cell tumor The U.S. Food and Drug Administration...
The FDA has approved an immunotherapy known as immune checkpoint inhibition for the treatment of certain patients with kidney...
THE FDA GRANTED ACCELERATED APPROVAL TO A TARGETED THERAPY FOR PATIENTS WITH CML RESISTANT TO OTHER THERAPEUTICS The U.S....
THE FDA APPROVED THE FIRST ADJUVANT IMMUNOTHERAPY FOR EARLY LUNG CANCER The U.S. Food and Drug Administration (FDA) granted...
THE FDA APPROVED THE IMMUNE CHECKPOINT INHIBITOR PEMBROLIZUMAB IN COMBINATION AND AS A SINGLE AGENT FOR ADVANCED CERVICAL CANCER...
THE FDA APPROVED A NEW TYPE OF CANCER INHIBITOR FOR CERTAIN PATIENTS WITH A HIGH RISK OF RECURRENCE The...